Skip to main content
. 2018 Apr 6;10:671–677. doi: 10.2147/CMAR.S163514

Table 1.

Patient characteristics in the study

Variable Total Low LND High LND P-value
Patients, n 1,924 1,641 283
Age (years), median (25th–75th percentile) 3 (2–5) 3 (2–5) 4 (3–6) <0.001
Sex, n (%) 0.529
 Male 917 (47.7) 787 (48.0) 130 (45.9)
 Female 1,007 (52.3) 854 (52.0) 153 (54.0)
Race, n (%) 0.196
 White 1,468 (76.3) 1,240 (75.6) 228 (80.6)
 Black 329 (17.1) 287(17.5) 42 (14.8)
 Other 105 (5.5) 94 (5.7) 11 (3.9)
LNs examined, median (25th–75th percentile) 4 (2–7) 4 (2–8) 3 (2–5) <0.001
SEER stage, n (%) <0.001
 Localized 832 (43.2) 832 (50.7) 0 (0.0)
 Regional 655 (34.0) 506 (30.8) 149 (52.7)
 Distant 417 (21.7) 283 (17.2) 134 (47.3)
Surgery, n (%) 0.584
 Yes 1,533 (79.7) 1,308 (79.7) 225 (79.5)
 No 6 (0.3) 6 (0.4) 0 (0.0)
 Unknown 385 (20.0) 327 (19.9) 58 (20.5)
Tumor laterality, n (%) 0.008
 Unilateral 1,840 (95.6) 1,561 (95.1) 279 (98.6)
 Bilateral 84 (4.4) 80 (4.9) 4 (1.4)
Year of diagnosis, n (%) 0.161
 1988 24 (1.2) 22 (1.3) 2 (0.7)
 1989–1997 359 (18.7) 303 (18.5) 56 (19.8)
 1998–2000 166 (8.6) 133 (8.1) 33 (11.7)
 2000–2014 1,375 (71.5) 1,183 (72.1) 192 (67.8)

Abbreviations: LNs, lymph nodes; LND, lymph node density; SEER, Surveillance, Epidemiology, and End Result.